| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $954K | — | -38.6% |
| R&D Expense | $600K | — | -94.7% |
| SG&A Expense | $14.4M | — | +36.3% |
| Operating Income | -$30.9M | — | -51.7% |
| Pre-tax Income | -$29.8M | — | -13.2% |
| Income Tax | $20K | — | -87.2% |
| Net Income | -$29.8M | — | -12.7% |
| EPS (Basic) | -$0.08 | — | +46.7% |
| EPS (Diluted) | -$0.08 | — | +46.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $43.1M | -49.5% | — |
| Accounts Receivable | $864K | +29.5% | — |
| Current Assets | $250.1M | -9.3% | — |
| Total Assets | $264.9M | -9.5% | — |
| Current Liabilities | $25.0M | +6.3% | — |
| Total Liabilities | $66.1M | -6.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$21.1M | — | -18.2% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$21.7M | — | -96.6% |
| Financing Cash Flow | $821K | — | -98.6% |
| Free Cash Flow | -$21.1M | — | -16.5% |
| Stockholders' Equity | $198.7M | -10.5% | +30.5% |